BioTheraVision, Inc.

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Quick facts

Phase 2 pipeline

BTV100 High dose · Oncology
BTV100 is a monoclonal antibody targeting CD19.
BTV100 Low dose
BTV100 Mid dose · Oncology
BTV100 is a monoclonal antibody targeting CD19.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

BioTheraVision, Inc. portfolio CI brief
BioTheraVision, Inc. pipeline updates RSS